Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy

Hepatitis due to hepatitis B virus (HBV) reactivation can be severe and potentially fatal, but is preventable. HBV reactivation is most commonly reported in patients receiving cancer chemotherapy, especially rituximab-containing therapy for hematological malignancies and those receiving stem cell tr...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:World J Gastroenterol
Hlavní autoři: Law, Man Fai, Ho, Rita, Cheung, Carmen K M, Tam, Lydia H P, Ma, Karen, So, Kent C Y, Ip, Bonaventure, So, Jacqueline, Lai, Jennifer, Ng, Joyce, Tam, Tommy H C
Médium: Artigo
Jazyk:Inglês
Vydáno: Baishideng Publishing Group Inc 2016
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4968128/
https://ncbi.nlm.nih.gov/pubmed/27605883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v22.i28.6484
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky